Preventing Overdiagnosis Evidence, Equity and Post Pandemic Health Care will be hosted by the University of Calgary, Alberta, Canada 9-12 June 2022.
We are accepting submissions for the Lisa M Schwartz 2022 scholarship, Poster, Oral, Workshop and Seminar presentations.
The submission deadline has been extended to April 14th.
Registration OPEN - Concession rates Available.
The Lisa M Schwartz Scholarship offers an opportunity that provides awardees with PODC registration, funding toward travel and accommodation and the opportunity to present at the conference. Submissions (made through the abstracts portal) should address an issue of relevance to Dr Schwartz work and interests, and be consistent with the vision and values Dr Schwartz championed in the communication of risk.
We are accepting abstracts against the following themes, however this list is by no means exhaustive and we welcome research abstracts and written perspective submissions on all aspects of Preventing Overdiagnosis:
• Equity & Equality: disparities in healthcare provision, marginalized populations, conflicts of interest driving inequity
• Sustainability and lessons learned from COVID-19: repurposing healthcare after a pandemic
• Medicalizing citizens: the harms of screening, disease thresholds, industry influences, the role of media
• The role of specialists in generating Overdiagnosis and their efforts to mitigate it
• Clinical Practice: Other dimensions of ODx, overtesting and the harms of too much medicine
As well as academic abstracts we are accepting written pieces according to your observations of, clinical/other work or related/lived experiences of Overdiagnosis. You might have a project proposal you are seeking collaborators for and would like feedback on before submitting for funding. Written pieces will be considered for presenting in a panel/seminar format with other related submissions.
Abstracts published and presented elsewhere will be given the opportunity to present and receive feedback at PODC 2022. However there will be no publication in the BMJ Evidence-Based Medicine supplement.
Abstracts submitted and delivered in the French language are very welcome.
